McLaren Greater Lansing — Lansing, Michigan

McLaren Greater Lansing is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

McLaren Greater Lansing has participated in 11 clinical trials with 7 currently active.

Therapeutic areas: Cardiovascular Risk, Acute Myocardial Infarction (AMI), Heart Failure.

Sponsors: Novo Nordisk A/S, Duke University, Shanghai MicroPort Medical (Group) Co., Ltd..

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McLaren Greater Lansing?

McLaren Greater Lansing has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McLaren Greater Lansing conducted?

McLaren Greater Lansing has 11 clinical trials on record, with 7 currently active. Their work covers Cardiovascular Risk, Acute Myocardial Infarction (AMI), Heart Failure.

Is McLaren Greater Lansing accredited by Crixeo Clinical Trials?

McLaren Greater Lansing has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McLaren Greater Lansing?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.